The document discusses the history and development of continuous ambulatory peritoneal dialysis (CAPD). It describes how in the 1960s intermittent peritoneal dialysis was used to treat patients with chronic renal failure. In the 1970s, Tenckhoff developed an indwelling catheter that led to the introduction of CAPD, where exchanges are done several times per day. The document provides details on peritoneal dialysis catheters and techniques, complications, anatomy and physiology related to peritoneal dialysis, and peritoneal dialysis fluid composition.
1. Dialysis adequacy refers to removing sufficient toxins and waste from the blood to prevent adverse health outcomes and is measured by urea clearance and nutritional intake.
2. Urea clearance is the standard measure and is expressed as Kt/V, with a target single pool Kt/V of at least 1.2 per session for patients receiving hemodialysis 3 times a week.
3. Other factors that determine adequacy include residual kidney function, nutrition as measured by normalized protein catabolic rate, and controlling symptoms like anemia, acidosis, and blood pressure.
This document discusses acute peritoneal dialysis. It notes that acute peritoneal dialysis provides a non-vascular alternative for dialysis that can be used in intensive care settings and is less expensive than other options. The advantages are that it is simpler than other dialysis methods and does not require specialized equipment or anticoagulation. However, it is less efficient than hemodialysis for acute issues and can cause substantial protein losses. Prescribing considerations include session length, exchange volume and time, dialysis solution dextrose concentration and additives, and monitoring fluid balance and clearance. Complications can include abdominal distention, peritonitis, hypotension, hyperglycemia, and hypoalbuminemia.
This document discusses the prescription of peritoneal dialysis, including the choice of modality (CAPD vs APD), clearance targets, and measurement of clearance through Kt/V and creatinine clearance. It also covers factors that determine clearance like residual renal function, body size, and transport characteristics. For CAPD and APD, prescription factors include exchange frequency and volume, and dwell times. Nutritional monitoring for PD patients includes nPNA, serum albumin, subjective global assessment, and lean body mass. Treatment of malnutrition may include dietitian support, supplements, promotility agents, steroids, and amino acids.
The document discusses complications of peritoneal dialysis, specifically peritonitis. It describes the typical presentation of peritonitis as abdominal pain and cloudy dialysate fluid. Causes include breaks in sterile technique or recent infections. Diagnosis requires abdominal pain and cloudy fluid with leukocytosis. Treatment involves empiric antibiotics targeting gram positive and negative organisms. Outcomes depend on causative organisms and whether the peritoneal catheter is infected.
CRRT involves continuous renal replacement therapies like hemodialysis, hemofiltration, and hemodiafiltration that are better tolerated for critically ill patients with AKI. They work through diffusion, convection, and adsorption using semipermeable membranes to filter waste and excess fluid at slower rates than intermittent dialysis. Common CRRT modalities include CVVH, CVVHD, and CVVHDF. While offering benefits over intermittent dialysis for hemodynamic stability and management of fluid, electrolytes and acids, CRRT can cause complications related to the vascular access and anticoagulation used.
This document discusses hemodialysis for acute kidney injury (AKI). It provides information on:
1. Hemodialysis is a form of renal replacement therapy that uses a dialyzer and extracorporeal circuit to partially replace kidney functions like fluid balance and waste removal when kidney function is insufficient.
2. The decision to start renal replacement therapy like hemodialysis for AKI is based on clinical signs of issues like volume overload or biochemical abnormalities rather than single thresholds, though emergencies require immediate dialysis.
3. The optimal timing of dialysis initiation for AKI is unclear, but observational studies suggest earlier initiation may improve outcomes compared to waiting for more severe clinical indications.
This document discusses the history and physiology of peritoneal dialysis. It describes how peritoneal dialysis evolved from early experiments in the 19th century to the development of continuous ambulatory peritoneal dialysis in the late 20th century. It also summarizes the anatomy of the peritoneum and various models that have been used to describe solute and fluid transport across the peritoneal membrane during dialysis.
The document discusses the history and development of continuous ambulatory peritoneal dialysis (CAPD). It describes how in the 1960s intermittent peritoneal dialysis was used to treat patients with chronic renal failure. In the 1970s, Tenckhoff developed an indwelling catheter that led to the introduction of CAPD, where exchanges are done several times per day. The document provides details on peritoneal dialysis catheters and techniques, complications, anatomy and physiology related to peritoneal dialysis, and peritoneal dialysis fluid composition.
1. Dialysis adequacy refers to removing sufficient toxins and waste from the blood to prevent adverse health outcomes and is measured by urea clearance and nutritional intake.
2. Urea clearance is the standard measure and is expressed as Kt/V, with a target single pool Kt/V of at least 1.2 per session for patients receiving hemodialysis 3 times a week.
3. Other factors that determine adequacy include residual kidney function, nutrition as measured by normalized protein catabolic rate, and controlling symptoms like anemia, acidosis, and blood pressure.
This document discusses acute peritoneal dialysis. It notes that acute peritoneal dialysis provides a non-vascular alternative for dialysis that can be used in intensive care settings and is less expensive than other options. The advantages are that it is simpler than other dialysis methods and does not require specialized equipment or anticoagulation. However, it is less efficient than hemodialysis for acute issues and can cause substantial protein losses. Prescribing considerations include session length, exchange volume and time, dialysis solution dextrose concentration and additives, and monitoring fluid balance and clearance. Complications can include abdominal distention, peritonitis, hypotension, hyperglycemia, and hypoalbuminemia.
This document discusses the prescription of peritoneal dialysis, including the choice of modality (CAPD vs APD), clearance targets, and measurement of clearance through Kt/V and creatinine clearance. It also covers factors that determine clearance like residual renal function, body size, and transport characteristics. For CAPD and APD, prescription factors include exchange frequency and volume, and dwell times. Nutritional monitoring for PD patients includes nPNA, serum albumin, subjective global assessment, and lean body mass. Treatment of malnutrition may include dietitian support, supplements, promotility agents, steroids, and amino acids.
The document discusses complications of peritoneal dialysis, specifically peritonitis. It describes the typical presentation of peritonitis as abdominal pain and cloudy dialysate fluid. Causes include breaks in sterile technique or recent infections. Diagnosis requires abdominal pain and cloudy fluid with leukocytosis. Treatment involves empiric antibiotics targeting gram positive and negative organisms. Outcomes depend on causative organisms and whether the peritoneal catheter is infected.
CRRT involves continuous renal replacement therapies like hemodialysis, hemofiltration, and hemodiafiltration that are better tolerated for critically ill patients with AKI. They work through diffusion, convection, and adsorption using semipermeable membranes to filter waste and excess fluid at slower rates than intermittent dialysis. Common CRRT modalities include CVVH, CVVHD, and CVVHDF. While offering benefits over intermittent dialysis for hemodynamic stability and management of fluid, electrolytes and acids, CRRT can cause complications related to the vascular access and anticoagulation used.
This document discusses hemodialysis for acute kidney injury (AKI). It provides information on:
1. Hemodialysis is a form of renal replacement therapy that uses a dialyzer and extracorporeal circuit to partially replace kidney functions like fluid balance and waste removal when kidney function is insufficient.
2. The decision to start renal replacement therapy like hemodialysis for AKI is based on clinical signs of issues like volume overload or biochemical abnormalities rather than single thresholds, though emergencies require immediate dialysis.
3. The optimal timing of dialysis initiation for AKI is unclear, but observational studies suggest earlier initiation may improve outcomes compared to waiting for more severe clinical indications.
This document discusses the history and physiology of peritoneal dialysis. It describes how peritoneal dialysis evolved from early experiments in the 19th century to the development of continuous ambulatory peritoneal dialysis in the late 20th century. It also summarizes the anatomy of the peritoneum and various models that have been used to describe solute and fluid transport across the peritoneal membrane during dialysis.
Water treatment and quality control of dialysate.Vishal Golay
The document discusses water treatment and quality control for dialysate used in hemodialysis. It describes the various components of a water treatment system, including backflow preventers, temperature blending valves, filters, softeners, carbon tanks, reverse osmosis membranes, and ultraviolet irradiation. The water treatment system aims to remove contaminants and achieve a composition similar to extracellular fluid for the dialysate. Proper functioning and monitoring of the water treatment system is important for patient safety and preventing toxic effects of contaminants.
This document summarizes key aspects of hemodialysis adequacy and dose. It discusses:
- Early studies that showed a correlation between dialysis dose and patient outcomes. The NCDS study in 1981 was the first randomized controlled trial showing higher Kt/V values were associated with better outcomes.
- Methods for measuring dialysis dose including Kt/V, eKt/V, URR. The preferred method is formal kinetic urea modeling.
- Guidelines recommend a minimum Kt/V of 1.2 or eKt/V of 1.2. Studies like HEMO showed no additional benefit to higher doses above 1.3-1.4.
- Maximizing
This document discusses common and less common complications that can occur during dialysis treatment. It provides details on the causes, symptoms, and management of various complications including hypotension, cramps, nausea/vomiting, headaches, and others. Potential complications are grouped as either common (occurring in 5-60% of treatments) or less common. Treatment approaches focus on prevention through careful fluid management and addressing underlying causes of complications when they arise.
Dialysis without anticoagulation (Heparin Free Dialysis)Mahmoud Eid
This document discusses techniques for performing dialysis without anticoagulation. It describes indications for heparin-free dialysis such as recent surgery or bleeding risks. Techniques mentioned include regional citrate anticoagulation, saline flushes, heparin-coated membranes, and citrasate dialysate. Signs of clotting and scoring systems are provided. Tips for priming, high blood flows, and alternatives to heparin locking are also outlined. The key recommendations are to prime properly, have no rushing, follow a written protocol, and focus on patient safety above all else.
This document discusses anticoagulation during hemodialysis. It begins by explaining coagulation and anticoagulants. Unfractionated heparin is the most commonly used anticoagulant for hemodialysis as it can be administered via infusion pumps and has a short half life. The maintenance dose is monitored via aPTT or ACT tests. Low molecular weight heparins are also used as they have fewer side effects compared to unfractionated heparin. Regional anticoagulation was used in the past but has been replaced by heparin-free techniques due to risks of rebound bleeding.
Patient selection and training for peritoneal dialysisAyman Seddik
This document discusses key considerations in assessing patients for peritoneal dialysis and initiating the therapy. It addresses issues like timing of catheter placement, adequacy of training, and management of early complications. Selection of appropriate patients and initiation of peritoneal dialysis is positioned as a multidisciplinary task requiring close monitoring by the renal team. Placement of the catheter 4-5 weeks before starting therapy and adherence to protocols for catheter care and training are emphasized.
Dialysis is used to treat kidney failure and manage its complications. There are different modalities including peritoneal dialysis, hemodialysis, and continuous renal replacement therapy. Hemodialysis uses a dialyzer, tubing, and machine to remove waste and fluid by diffusion and ultrafiltration as blood and dialysate flow countercurrently. Vascular access includes catheters, arteriovenous grafts, and arteriovenous fistulas. Complications can include infections, thrombosis, and fluid overload.
This document discusses the history of hemodialysis. It describes how Thomas Graham first presented principles of solute transport across membranes in 1854. Willem Kolff constructed the first working dialyzer in 1943 and successfully treated a patient in renal failure in 1945, though it was initially only intended for acute cases. By the 1960s, dialysis was being used to treat chronic renal failure but demand exceeded capacity, requiring decisions on patient selection.
Dialysis various modalities and indices usedAbhay Mange
Dialysis is a process used to remove waste and excess water from the blood of patients with kidney failure. There are various modalities of dialysis including intermittent hemodialysis, peritoneal dialysis, and continuous renal replacement therapy. Hemodialysis uses diffusion and ultrafiltration across a semi-permeable membrane in a dialyzer to clean the blood. Proper vascular access and anticoagulation are also important aspects of hemodialysis treatment.
The document summarizes potential complications of peritoneal dialysis catheters including malfunctioning catheters, early and late non-functioning, and causes such as constipation, intra-abdominal adhesions from previous surgery or peritonitis, catheter migration, blood or fibrin blocking the catheter, and hernias. It describes methods for investigating malfunctioning catheters including abdominal x-rays, x-rays with contrast dye, and CT scans. It provides guidance on managing different causes through measures like laxatives, re-siting the catheter, adding heparin to dialysate, or removing the catheter.
This document discusses evaluating the adequacy of hemodialysis treatment. It states that numerous studies have shown a correlation between the delivered dose of hemodialysis and patient mortality and morbidity. The urea reduction ratio (URR), which measures the percentage reduction of urea levels pre- and post-dialysis, is one way to evaluate adequacy, with a URR over 60% generally associated with better outcomes. Equilibrated Kt/V is also discussed as a standard measure of dialysis dose, with a minimum of 1.4 recommended. The document outlines factors that influence adequacy, including treatment time and frequency, dialyzer characteristics, blood and dialysate flow rates, and dialysis solution composition
Dialysis dose prescription (the basics) dr ujjawalUjjawal Roy
The document discusses key aspects of dialysis dose prescription, including:
1) Components of the dialysis prescription include dialyzer choice, time, blood and dialysate flow rates, ultrafiltration rate, dialysate composition, temperature, and anticoagulation.
2) Prescription goals are to restore the body's fluid and electrolyte balance and remove waste and excess water from patients with end-stage renal disease.
3) Important considerations for dialysis prescription include a patient's dry weight and risk of intradialytic hypotension.
This document discusses permanent vascular access for hemodialysis. It describes the formation and types of arteriovenous fistulae (AVF) and synthetic grafts. AVFs involve surgically connecting an artery and vein and are the preferred permanent access. Synthetic grafts are used when vessels are unsuitable for an AVF. Complications of access include stenosis, thrombosis, ischemia, pseudoaneurysms and infection. Care of the access involves monitoring for complications, proper needle placement and infection prevention.
1. Anticoagulation is required for hemodialysis due to the activation of coagulation pathways from turbulent blood flow through the dialysis circuit.
2. Standard-risk patients are typically treated with unfractionated heparin or low molecular weight heparin to prevent clotting during the procedure.
3. High bleeding risk patients and those with heparin-induced thrombocytopenia are treated using a "no-heparin" method to avoid systemic anticoagulation.
This document provides an overview of anticoagulation options for hemodialysis. It discusses conventional anticoagulants like unfractionated heparin and low molecular weight heparins. It also covers newer direct thrombin inhibitors and regional anticoagulation methods using citrate or prostacyclin. The risks and benefits of each option are evaluated based on bleeding risks, reversibility, cost, and ability to prevent clotting during hemodialysis procedures. Monitoring requirements and dosing protocols are also reviewed for different anticoagulant regimens.
CRRT is a continuous renal replacement therapy that provides a gentler form of dialysis for critically ill patients. It works through slow, continuous removal of waste and fluid over multiple days rather than the typical 4 hour sessions of hemodialysis. This puts less stress on the heart. CRRT can be delivered through various modes including continuous venovenous hemofiltration, hemodialysis, or hemodiafiltration that utilize diffusion, convection, or both to clean the blood. Anticoagulation is required to prevent clotting of the dialysis circuit and can include regional citrate or low-dose heparin.
This document discusses exit site infections in peritoneal dialysis patients. It defines acute and chronic exit site infections and notes that approximately one fifth of peritonitis episodes are associated with exit or tunnel infections. Exit site infections are commonly caused by Staphylococcus aureus or Gram-negative bacteria like Pseudomonas. Treatment depends on the severity and causative organism but may include antibiotics, changing the exit site dressing, or catheter removal in severe cases. Preventing exit site infections through good catheter care and possibly antibiotic prophylaxis can help reduce risks of peritonitis and catheter loss.
This document summarizes some of the metabolic complications that can occur with peritoneal dialysis (PD). It notes that while PD is generally well-tolerated, it can lead to issues like glucose absorption, protein loss, and lipid abnormalities. Glucose is used as the osmotic agent in PD fluid and is readily absorbed, which can cause hyperinsulinemia and hypertriglyceridemia in patients. Protein is also lost across the peritoneum in PD. Electrolyte imbalances like hyponatremia, hypernatremia, hypokalemia, hyperkalemia, hypocalcemia, and hypermagnesemia can arise depending on the composition of the dialysate fluid and
This document discusses different types of vascular access for hemodialysis, including arteriovenous fistulas, grafts, and catheters. It provides details on the anatomy of veins in the upper limbs that are used for access. Native fistulas have the highest patency rates and lowest infection risks compared to other options. Examination of vascular accesses involves inspection, palpation, and auscultation to evaluate for abnormalities. The conclusion recommends arteriovenous fistulas as the preferred long-term access due to lower complication rates.
18 Use Of Peritoneal Dialysis For The Treatment Of Acute Renal FailureDang Thanh Tuan
1) Acute peritoneal dialysis (PD) is an option for treating selected acute renal failure patients, especially those who are hemodynamically unstable or have coagulation abnormalities.
2) A study compared PD to hemofiltration for acute renal failure patients with malaria or sepsis in Vietnam and found that hemofiltration corrected metabolic abnormalities faster and had lower mortality.
3) The poorer outcomes with PD may have been due to its less optimal technique in this setting, with slower solute removal compared to hemofiltration.
UF vs diuretics in treatment of ADHF, Cardiorenal syndrome Mohamed E. Elrggal
1. Fluid overload and congestion are major characteristics of heart failure (HF) that are important treatment targets. Diuretics have limitations like resistance and worsening renal function.
2. Ultrafiltration (UF) theoretically has advantages over diuretics for acute decompensated heart failure (ADHF) by allowing faster fluid removal without electrolyte issues.
3. However, clinical trials have had conflicting results. The UNLOAD trial found greater benefits with UF, while the CARESS-HF trial found increased renal dysfunction and adverse events with UF.
4. Further research is needed to determine optimal patient selection, monitoring of plasma refill rate during UF, and long-term outcomes comparison
Water treatment and quality control of dialysate.Vishal Golay
The document discusses water treatment and quality control for dialysate used in hemodialysis. It describes the various components of a water treatment system, including backflow preventers, temperature blending valves, filters, softeners, carbon tanks, reverse osmosis membranes, and ultraviolet irradiation. The water treatment system aims to remove contaminants and achieve a composition similar to extracellular fluid for the dialysate. Proper functioning and monitoring of the water treatment system is important for patient safety and preventing toxic effects of contaminants.
This document summarizes key aspects of hemodialysis adequacy and dose. It discusses:
- Early studies that showed a correlation between dialysis dose and patient outcomes. The NCDS study in 1981 was the first randomized controlled trial showing higher Kt/V values were associated with better outcomes.
- Methods for measuring dialysis dose including Kt/V, eKt/V, URR. The preferred method is formal kinetic urea modeling.
- Guidelines recommend a minimum Kt/V of 1.2 or eKt/V of 1.2. Studies like HEMO showed no additional benefit to higher doses above 1.3-1.4.
- Maximizing
This document discusses common and less common complications that can occur during dialysis treatment. It provides details on the causes, symptoms, and management of various complications including hypotension, cramps, nausea/vomiting, headaches, and others. Potential complications are grouped as either common (occurring in 5-60% of treatments) or less common. Treatment approaches focus on prevention through careful fluid management and addressing underlying causes of complications when they arise.
Dialysis without anticoagulation (Heparin Free Dialysis)Mahmoud Eid
This document discusses techniques for performing dialysis without anticoagulation. It describes indications for heparin-free dialysis such as recent surgery or bleeding risks. Techniques mentioned include regional citrate anticoagulation, saline flushes, heparin-coated membranes, and citrasate dialysate. Signs of clotting and scoring systems are provided. Tips for priming, high blood flows, and alternatives to heparin locking are also outlined. The key recommendations are to prime properly, have no rushing, follow a written protocol, and focus on patient safety above all else.
This document discusses anticoagulation during hemodialysis. It begins by explaining coagulation and anticoagulants. Unfractionated heparin is the most commonly used anticoagulant for hemodialysis as it can be administered via infusion pumps and has a short half life. The maintenance dose is monitored via aPTT or ACT tests. Low molecular weight heparins are also used as they have fewer side effects compared to unfractionated heparin. Regional anticoagulation was used in the past but has been replaced by heparin-free techniques due to risks of rebound bleeding.
Patient selection and training for peritoneal dialysisAyman Seddik
This document discusses key considerations in assessing patients for peritoneal dialysis and initiating the therapy. It addresses issues like timing of catheter placement, adequacy of training, and management of early complications. Selection of appropriate patients and initiation of peritoneal dialysis is positioned as a multidisciplinary task requiring close monitoring by the renal team. Placement of the catheter 4-5 weeks before starting therapy and adherence to protocols for catheter care and training are emphasized.
Dialysis is used to treat kidney failure and manage its complications. There are different modalities including peritoneal dialysis, hemodialysis, and continuous renal replacement therapy. Hemodialysis uses a dialyzer, tubing, and machine to remove waste and fluid by diffusion and ultrafiltration as blood and dialysate flow countercurrently. Vascular access includes catheters, arteriovenous grafts, and arteriovenous fistulas. Complications can include infections, thrombosis, and fluid overload.
This document discusses the history of hemodialysis. It describes how Thomas Graham first presented principles of solute transport across membranes in 1854. Willem Kolff constructed the first working dialyzer in 1943 and successfully treated a patient in renal failure in 1945, though it was initially only intended for acute cases. By the 1960s, dialysis was being used to treat chronic renal failure but demand exceeded capacity, requiring decisions on patient selection.
Dialysis various modalities and indices usedAbhay Mange
Dialysis is a process used to remove waste and excess water from the blood of patients with kidney failure. There are various modalities of dialysis including intermittent hemodialysis, peritoneal dialysis, and continuous renal replacement therapy. Hemodialysis uses diffusion and ultrafiltration across a semi-permeable membrane in a dialyzer to clean the blood. Proper vascular access and anticoagulation are also important aspects of hemodialysis treatment.
The document summarizes potential complications of peritoneal dialysis catheters including malfunctioning catheters, early and late non-functioning, and causes such as constipation, intra-abdominal adhesions from previous surgery or peritonitis, catheter migration, blood or fibrin blocking the catheter, and hernias. It describes methods for investigating malfunctioning catheters including abdominal x-rays, x-rays with contrast dye, and CT scans. It provides guidance on managing different causes through measures like laxatives, re-siting the catheter, adding heparin to dialysate, or removing the catheter.
This document discusses evaluating the adequacy of hemodialysis treatment. It states that numerous studies have shown a correlation between the delivered dose of hemodialysis and patient mortality and morbidity. The urea reduction ratio (URR), which measures the percentage reduction of urea levels pre- and post-dialysis, is one way to evaluate adequacy, with a URR over 60% generally associated with better outcomes. Equilibrated Kt/V is also discussed as a standard measure of dialysis dose, with a minimum of 1.4 recommended. The document outlines factors that influence adequacy, including treatment time and frequency, dialyzer characteristics, blood and dialysate flow rates, and dialysis solution composition
Dialysis dose prescription (the basics) dr ujjawalUjjawal Roy
The document discusses key aspects of dialysis dose prescription, including:
1) Components of the dialysis prescription include dialyzer choice, time, blood and dialysate flow rates, ultrafiltration rate, dialysate composition, temperature, and anticoagulation.
2) Prescription goals are to restore the body's fluid and electrolyte balance and remove waste and excess water from patients with end-stage renal disease.
3) Important considerations for dialysis prescription include a patient's dry weight and risk of intradialytic hypotension.
This document discusses permanent vascular access for hemodialysis. It describes the formation and types of arteriovenous fistulae (AVF) and synthetic grafts. AVFs involve surgically connecting an artery and vein and are the preferred permanent access. Synthetic grafts are used when vessels are unsuitable for an AVF. Complications of access include stenosis, thrombosis, ischemia, pseudoaneurysms and infection. Care of the access involves monitoring for complications, proper needle placement and infection prevention.
1. Anticoagulation is required for hemodialysis due to the activation of coagulation pathways from turbulent blood flow through the dialysis circuit.
2. Standard-risk patients are typically treated with unfractionated heparin or low molecular weight heparin to prevent clotting during the procedure.
3. High bleeding risk patients and those with heparin-induced thrombocytopenia are treated using a "no-heparin" method to avoid systemic anticoagulation.
This document provides an overview of anticoagulation options for hemodialysis. It discusses conventional anticoagulants like unfractionated heparin and low molecular weight heparins. It also covers newer direct thrombin inhibitors and regional anticoagulation methods using citrate or prostacyclin. The risks and benefits of each option are evaluated based on bleeding risks, reversibility, cost, and ability to prevent clotting during hemodialysis procedures. Monitoring requirements and dosing protocols are also reviewed for different anticoagulant regimens.
CRRT is a continuous renal replacement therapy that provides a gentler form of dialysis for critically ill patients. It works through slow, continuous removal of waste and fluid over multiple days rather than the typical 4 hour sessions of hemodialysis. This puts less stress on the heart. CRRT can be delivered through various modes including continuous venovenous hemofiltration, hemodialysis, or hemodiafiltration that utilize diffusion, convection, or both to clean the blood. Anticoagulation is required to prevent clotting of the dialysis circuit and can include regional citrate or low-dose heparin.
This document discusses exit site infections in peritoneal dialysis patients. It defines acute and chronic exit site infections and notes that approximately one fifth of peritonitis episodes are associated with exit or tunnel infections. Exit site infections are commonly caused by Staphylococcus aureus or Gram-negative bacteria like Pseudomonas. Treatment depends on the severity and causative organism but may include antibiotics, changing the exit site dressing, or catheter removal in severe cases. Preventing exit site infections through good catheter care and possibly antibiotic prophylaxis can help reduce risks of peritonitis and catheter loss.
This document summarizes some of the metabolic complications that can occur with peritoneal dialysis (PD). It notes that while PD is generally well-tolerated, it can lead to issues like glucose absorption, protein loss, and lipid abnormalities. Glucose is used as the osmotic agent in PD fluid and is readily absorbed, which can cause hyperinsulinemia and hypertriglyceridemia in patients. Protein is also lost across the peritoneum in PD. Electrolyte imbalances like hyponatremia, hypernatremia, hypokalemia, hyperkalemia, hypocalcemia, and hypermagnesemia can arise depending on the composition of the dialysate fluid and
This document discusses different types of vascular access for hemodialysis, including arteriovenous fistulas, grafts, and catheters. It provides details on the anatomy of veins in the upper limbs that are used for access. Native fistulas have the highest patency rates and lowest infection risks compared to other options. Examination of vascular accesses involves inspection, palpation, and auscultation to evaluate for abnormalities. The conclusion recommends arteriovenous fistulas as the preferred long-term access due to lower complication rates.
18 Use Of Peritoneal Dialysis For The Treatment Of Acute Renal FailureDang Thanh Tuan
1) Acute peritoneal dialysis (PD) is an option for treating selected acute renal failure patients, especially those who are hemodynamically unstable or have coagulation abnormalities.
2) A study compared PD to hemofiltration for acute renal failure patients with malaria or sepsis in Vietnam and found that hemofiltration corrected metabolic abnormalities faster and had lower mortality.
3) The poorer outcomes with PD may have been due to its less optimal technique in this setting, with slower solute removal compared to hemofiltration.
UF vs diuretics in treatment of ADHF, Cardiorenal syndrome Mohamed E. Elrggal
1. Fluid overload and congestion are major characteristics of heart failure (HF) that are important treatment targets. Diuretics have limitations like resistance and worsening renal function.
2. Ultrafiltration (UF) theoretically has advantages over diuretics for acute decompensated heart failure (ADHF) by allowing faster fluid removal without electrolyte issues.
3. However, clinical trials have had conflicting results. The UNLOAD trial found greater benefits with UF, while the CARESS-HF trial found increased renal dysfunction and adverse events with UF.
4. Further research is needed to determine optimal patient selection, monitoring of plasma refill rate during UF, and long-term outcomes comparison
This document provides information on acute renal failure (ARF) including the causes, types, assessment, differential testing, management, and nursing care of patients with ARF requiring dialysis. It discusses the three main types of ARF - prerenal, intrarenal, and postrenal - and covers topics like fluid management, electrolyte imbalances, and the advantages and disadvantages of different renal replacement therapies including peritoneal dialysis, continuous renal replacement therapies, and hemodialysis.
This document discusses renal replacement therapy (RRT) in children, including peritoneal dialysis (PD). It provides an overview of indications for RRT, including refractory fluid overload, severe hyperkalemia, signs of uremia, severe metabolic acidosis, and certain drug intoxications. Modalities of RRT discussed include PD, intermittent hemodialysis, and continuous renal replacement therapy. PD is described as exchanging solutes and water between the blood and peritoneal membrane using a dialysis solution. Advantages of PD include being simple to perform and not requiring anticoagulation, while disadvantages include slow removal and unreliable ultrafiltration.
Renal failure and renal replacement therapyIvan Luyimbazi
This document provides information on chronic kidney disease (CKD), its stages and management through renal replacement therapies like hemodialysis and peritoneal dialysis. It describes the pathophysiology and risk factors for CKD and outlines the clinical presentation of renal failure. It then discusses the treatment options for end stage renal disease, including the general principles, procedures and nursing care involved in hemodialysis and peritoneal dialysis. Complications associated with each modality are also summarized.
Renal failure and renal replacement therapyIvan Luyimbazi
This document discusses chronic kidney disease (CKD) and renal replacement therapy. It defines CKD and its stages based on glomerular filtration rate. The main treatment options for end-stage renal disease are hemodialysis and peritoneal dialysis. Hemodialysis involves circulating the patient's blood through a dialysis machine to remove waste via diffusion across a semi-permeable membrane. Peritoneal dialysis utilizes the peritoneal membrane and infuses dialysate into the peritoneal cavity to remove waste via diffusion and osmosis. Complications, nursing care and procedures are discussed for both treatment modalities.
This document discusses the clinical management of acute renal failure in obstetric patients. It notes that oliguria is common during pregnancy and postpartum and can be caused by issues like preeclampsia. Conservative management is emphasized, including careful fluid management, monitoring of electrolytes and urine output. Diuretics may help management but are not proven to impact outcomes. Dialysis is indicated for issues like fluid overload, severe hyperkalemia or acidosis, or refractory uremic symptoms. Patients not responding to initial measures or with severe preeclampsia may require specialist care and invasive monitoring.
Preparation of pts with Renal ds for Routine Surgery-18.07.09.pptdeepti sharma
This document discusses the management of a post-renal transplant patient for surgery. Key points include:
- Post-transplant patients have altered physiology due to immunosuppression and potential drug interactions. Their medical history is often complex.
- Common medical problems include cardiovascular issues like hypertension and hyperlipidemia. Immunosuppressants can cause side effects like nephrotoxicity and increased risk of infections.
- A thorough preoperative evaluation of the patient's medical history, current medications and laboratory values is important due to the complexity of managing these high-risk patients undergoing surgery.
This document discusses the management of patients with obstructive jaundice undergoing surgery. It notes that jaundice results from increased bilirubin in the body due to obstruction of bile flow from the liver. Surgery in jaundiced patients carries risks, so careful preoperative assessment and perioperative management is needed to address nutritional deficiencies, cardiovascular and renal issues. The key is to maintain fluid balance and oxygen delivery while minimizing stress on the liver and kidneys.
Hemodialysis is a type of dialysis that relies on diffusion of solutes across a semipermeable membrane. It is used to treat end-stage kidney disease and involves circulating blood through a dialyzer while dialysate fluid passes on the outside of the fibers. Peritoneal dialysis infuses dialysate fluid into the peritoneal cavity, allowing diffusion and ultrafiltration of solutes. Both have risks like infections, metabolic complications, and encapsulating peritoneal sclerosis. Kidney transplantation is the treatment of choice for advanced kidney failure and has better outcomes than long-term dialysis, but requires lifelong immunosuppression.
The document discusses dialysis as a renal replacement therapy for patients with kidney failure or injury. It describes the process of diffusion and ultrafiltration that occurs during hemodialysis and peritoneal dialysis to remove waste and excess fluid. Complications related to each type of dialysis are also outlined. Nursing considerations are provided for pre-dialysis assessment, monitoring patients during treatment, and post-dialysis care.
Chronic renal failure or chronic kidney disease management, pharmacist role, medical management objectives, goals of the therapy .
What are the risk factors of chronic renal failure, clinical manifestations of chronic renal failure, renal failure complications, pathophysiology of chronic renal failure.
This document provides information on acute and chronic renal failure, including causes, pathophysiology, assessment, diagnosis, complications, nursing diagnoses, and nursing care. Acute renal failure can be pre-renal, intra-renal, or post-renal and is caused by decreased blood flow or obstruction. Chronic renal failure is a progressive loss of kidney function over time due to various injuries and diseases. Common complications include fluid imbalance, electrolyte abnormalities, nutritional deficits, and increased risk of infection or cardiovascular issues. Nursing focuses on monitoring fluid status, diet, nutrition, and treating related symptoms and complications.
Acute renal failure nursing care plan & managementNursing Path
Is a sudden decline in renal function, usually marked by increased concentrations of blood urea nitrogen (BUN; azotemia) and creatinine; oliguria (less than 500 ml of urine in 24 hours); hyperkalemia; and sodium retention.
PD THE ROAD LESS TRAVELLED Dr Ayman Seddik 2.pdfAyman Seddik
1. The document discusses guidelines for the prevention and management of peritonitis from the ISPD 2022 updates. It focuses on key areas such as the standardized definitions of peritonitis, measurement of peritonitis rates, prevention strategies like exit site care and antibiotic prophylaxis, and treatment recommendations.
2. The new guidelines recommend monitoring peritonitis rates and aiming for a rate of less than 0.4 episodes per patient year. Prevention strategies discussed include proper exit site care, antibiotic prophylaxis before catheter placement and invasive procedures, and patient education.
3. Treatment guidelines cover initial antibiotic therapy based on peritonitis type and symptoms, and monitoring response and indications for catheter removal. Overall the document summar
This document provides recommendations from a consensus of UK medical associations regarding intravenous fluid therapy for adult surgical patients. It aims to address concerns about high rates of postoperative sodium and water overload. The recommendations cover preoperative, intraoperative, and postoperative fluid management, with an emphasis on using balanced crystalloid solutions over saline. Close monitoring of fluid balance and electrolytes is advised. Higher molecular weight starches should be avoided in patients with sepsis or kidney injury due to risks of kidney damage.
Hepatorenal syndrome (HRS) is a severe complication of advanced liver cirrhosis that results in kidney dysfunction due to reduced renal blood flow. It occurs in 25-50% of hospitalized cirrhotic patients and has a high mortality rate. HRS is classified into type 1 (acute) and type 2 (chronic) based on the rapidity of kidney function decline. Treatment involves volume expansion with albumin, vasoconstrictors like terlipressin to constrict splanchnic vessels, and procedures like TIPS or liver transplantation to reduce portal hypertension and correct the underlying liver disease.
This case involves a 60-year-old black American woman admitted to the hospital with acute renal failure (ARF). She has a history of hypertension and diabetes. Tests show elevated potassium, BUN, and creatinine levels indicating kidney dysfunction. She is diagnosed with ARF secondary to congestive heart failure. Treatment involves hemodialysis, IV fluids, medication to lower potassium, and monitoring for complications of ARF like hyperkalemia.
acute kidney injury during pregnancy, challenges in diagnosis and treatmentMarwa Elkaref
This document discusses acute kidney injury (AKI) during pregnancy. It begins by explaining the physiological changes in pregnancy that make diagnosing AKI difficult. It then discusses the causes and classifications of AKI during pregnancy. Some key causes mentioned include preeclampsia, HELLP syndrome, and septic abortion. The document outlines supportive management of renal function as well as treating the underlying disease. It notes that dialysis may be needed if other procedures are insufficient.
This document provides an overview of acute kidney injury (AKI), chronic kidney disease (CKD), end-stage renal disease (ESRD), and their treatment and management. It discusses the pathophysiology, stages, symptoms, complications, medical and surgical interventions, and nursing care for each condition. Dialysis methods like hemodialysis and peritoneal dialysis are explained in detail. Surgical procedures for the kidneys like nephrectomy and transplantation are also summarized.
Similar to Volume status and fluid overload in peritoneal dialysis (20)
Peritonitis is an infection or inflammation of the peritoneum, which is the membrane lining the abdominal cavity. Potential routes of infection include intraluminal, periluminal, transmural, hematogenous, and transvaginal. Staphylococcus epidermidis is the most common causative organism. Treatment involves administering intraperitoneal antibiotics such as cefazolin and gentamicin to achieve high antibiotic concentrations in the peritoneum. Initial treatment lasts 3 days followed by adjustment of antibiotics based on culture results and response to treatment. Prevention strategies include careful patient selection, training, and ensuring proper exchange techniques.
This document discusses plasmapheresis, which is a therapeutic apheresis procedure that removes plasma from the blood. There are two main techniques used: membrane apheresis, which is fast but limited in substance removal, and centrifugal devices, which are more expensive but efficient. Complications can include hypotension, bleeding, and allergic reactions. Plasmapheresis is used to treat autoimmune disorders by removing autoantibodies, and other conditions involving abnormal circulating factors. Care must be taken with anticoagulation and replacement fluids during the procedure.
The document discusses factors to consider for a patient's first dialysis session for end-stage renal disease including using heparin-free anticoagulation, limiting fluid removal to 2 liters, using a bicarbonate dialysate, and having skilled medical staff present. It also provides guidelines for initial settings for a first session such as a blood flow rate of 150-200 ml/min, a dialysis time of 60-90 minutes, and a dialysate potassium level of 4-4.5 mmol/L. Precautions are recommended when initiating and terminating dialysis to ensure patient safety.
This document discusses anticoagulation during hemodialysis. It begins by explaining coagulation and anticoagulants. It then discusses how hemodialysis can activate coagulation pathways due to interactions with artificial surfaces. Unfractionated heparin is most commonly used for anticoagulation during dialysis due to its low cost and short half-life, though it carries bleeding risks. Low molecular weight heparins are also used and provide benefits like less bleeding risk. Anticoagulation is monitored during dialysis through tests like aPTT and ACT to prevent clotting while limiting bleeding risks.
Ultrafiltration is the process of removing water from the bloodstream during hemodialysis to achieve solute clearance and adequate fluid removal. There are two main methods of controlling ultrafiltration: pressure control, where blood compartment pressure is increased to remove fluid, and volumetric control, which directly measures ultrafiltrate volume for more accurate control. High efficiency dialysis aims for high urea and solute clearance rates using large surface area membranes and optimized blood and dialysate flows. High flux dialysis uses more permeable membranes to improve clearance of middle and large molecules. Hemofiltration provides solute clearance solely through convection while hemodiafiltration combines dialysis with large volume ultrafiltration for combined con
- An average hemodialysis patient is exposed to 560 liters of water through weekly treatments, more than most people use in a lifetime. Proper water treatment is important to remove impurities and minerals that can be toxic to patients or damage equipment.
- Water is treated through pre-treatment including filtration, softening, and carbon adsorption. Primary purification uses reverse osmosis or deionization to remove 95% of contaminants. Purified water is then distributed through disinfected piping to avoid microbiological contamination.
- Standards are in place to ensure safe water purification for dialysis and protect patients from issues like anemia, bone disease, or infection.
The document summarizes the key features of dialysis machines, including their blood pump, dialysate delivery system, safety monitors, and options. The blood pump circulates blood through the dialyzer. The dialysate delivery system prepares and regulates dialysate flow and composition. Safety monitors include arterial and venous pressure monitors, air detectors, and monitors for dialysate conductivity, temperature, and blood leaks. Dialysis machines also have options like a heparin pump and controls for ultrafiltration and disinfection procedures help control bacterial contamination.
Diarrhea can cause or worsen kidney failure by reducing blood flow to the kidneys. Diarrhea leads to dehydration, electrolyte imbalances, and malnutrition, impairing kidney function and potentially causing kidney failure. While most cases of renal failure from diarrhea can be treated successfully, 10-20% of patients may not fully recover kidney function and require long-term dialysis. Diarrhea is usually diagnosed and treated by replacing lost fluids to prevent dehydration, and identifying and treating its underlying cause such as infection.
This document discusses kidney failure caused by hypertension. It begins by defining blood pressure and the stages of hypertension. It then explains how high blood pressure can damage the kidneys over time by restricting blood flow. Specifically, it describes how narrowing of the renal arteries from conditions like atherosclerosis and fibromuscular dysplasia can lead to renal hypertension. Left untreated, this causes further kidney damage through activation of the renin-angiotensin system and fluid retention, eventually leading to kidney failure and the need for dialysis or transplantation. The document outlines symptoms, diagnostic tests, prevention methods like controlling blood pressure, and treatments including medications and revascularization.
Diabetic kidney disease, also called diabetic nephropathy, is a type of chronic kidney disease caused by damage to the kidneys as a result of diabetes. Over time, high blood glucose levels associated with diabetes can damage the tiny filters in the kidneys called glomeruli. This can progressively reduce their ability to filter waste from the blood, potentially leading to kidney failure. Symptoms of diabetic kidney disease may include swelling, poor sleep or concentration, nausea or weakness. It can be diagnosed through urine and blood tests and managed through strict control of blood sugar and blood pressure levels.
This document discusses the autonomic nervous system and cholinergic neurotransmission. It describes the sympathetic and parasympathetic divisions of the ANS, their pathways and neurotransmitters. Acetylcholine is the primary neurotransmitter of the cholinergic system. The document outlines the synthesis, storage, release and degradation of acetylcholine, as well as the types and functions of muscarinic and nicotinic receptors. It also discusses the mechanisms and therapeutic uses of cholinergic agonists and anticholinesterases, along with their side effects.
The document discusses various concepts related to pharmacology including dose-response relationships, drug potency and efficacy, therapeutic index, and factors that can influence drug response. It describes the graded and quantal types of dose-response curves and defines potency as the amount of drug required to produce a desired response. Therapeutic index is defined as the ratio of lethal to effective doses. The document also discusses how drug responses can be increased or decreased through summation, synergism, potentiation, and antagonism. Multiple factors are described that can affect drug response including route of administration, presence of other drugs, accumulation, and patient-related factors.
1. There are several routes of drug administration including enteral, parenteral, local, and topical routes. The choice of route depends on factors like the drug properties, site of action, rate of absorption, and patient condition.
2. Enteral routes include oral, rectal, buccal, and sublingual administration. Parenteral routes involve direct delivery into the systemic circulation via injections like intravenous, intramuscular, or subcutaneous. Local routes target specific sites and topical routes apply drugs to external surfaces.
3. Each route has advantages and disadvantages related to factors like absorption, onset of action, safety, patient acceptability, and cost. The optimal route maximizes drug delivery while avoiding
This document discusses pharmacodynamics, which refers to how drugs act on the body. It describes different types of drug actions like stimulation, depression, irritation, and replacement. The mechanisms of drug action are either receptor-mediated or non-receptor mediated. Non-receptor mediated mechanisms include physical actions like osmosis, chemical actions like acids neutralizing gastric acid, and actions through enzymes, ion channels, antibody production, and transporters. Receptor-mediated mechanisms involve drugs binding to receptors on cells and can be agonists, antagonists, partial agonists, or inverse agonists. The main receptor families are ligand-gated ion channels, G-protein coupled receptors, enzymatic receptors, and nuclear receptors.
This document discusses various concepts related to pharmacokinetics including drug absorption, distribution, metabolism, and excretion. It describes how drugs pass through cell membranes via passive diffusion, facilitated transport, or active transport. Factors affecting drug absorption like solubility, ionization, and pharmaceutical formulation are also summarized. The concepts of bioavailability, plasma half-life, and steady state are defined. The document also discusses distribution of drugs to tissues, factors influencing distribution, and drug clearance through metabolism and excretion.
This document discusses the history of hemodialysis. It describes how Thomas Graham first presented principles of solute transport across membranes in 1854. Willem Kolff constructed the first working dialyzer in 1943 and successfully treated a patient in renal failure in 1945, though it was initially only intended for acute cases. By the 1960s, dialysis was being used to treat chronic renal failure but demand exceeded capacity, requiring decisions on patient selection.
This document discusses dialyzers, which are used in renal dialysis to remove waste and excess fluid from the blood of patients with kidney failure. It describes the key components of a dialyzer, including the semipermeable membrane and four ports, as well as specifications like surface area, clearance rates, and sterilization methods. Various types of dialyzers are covered, such as coil dialyzers, parallel plate dialyzers, and hollow fiber dialyzers. Membrane materials including cellulose, synthetic, and cellulosynthetic are also outlined. An ideal dialyzer is said to efficiently clear toxins while avoiding protein and cell losses.
Chronic renal failure involves the progressive and irreversible loss of kidney function, defined as a GFR of less than 60 ml/min/1.73 m2 or the presence of kidney damage. Symptoms depend on the underlying renal disease and may include lethargy, edema, hypertension, and laboratory findings like elevated BUN and creatinine. Treatment aims to replace lost renal function through dialysis and slow the progression of renal dysfunction.
Health Tech Market Intelligence Prelim Questions -Gokul Rangarajan
The Ultimate Guide to Setting up Market Research in Health Tech part -1
How to effectively start market research in the health tech industry by defining objectives, crafting problem statements, selecting methods, identifying data collection sources, and setting clear timelines. This guide covers all the preliminary steps needed to lay a strong foundation for your research.
This lays foundation of scoping research project what are the
Before embarking on a research project, especially one aimed at scoping and defining parameters like the one described for health tech IT, several crucial considerations should be addressed. Here’s a comprehensive guide covering key aspects to ensure a well-structured and successful research initiative:
1. Define Research Objectives and Scope
Clear Objectives: Define specific goals such as understanding market needs, identifying new opportunities, assessing risks, or refining pricing strategies.
Scope Definition: Clearly outline the boundaries of the research in terms of geographical focus, target demographics (e.g., age, socio-economic status), and industry sectors (e.g., healthcare IT).
3. Review Existing Literature and Resources
Literature Review: Conduct a thorough review of existing research, market reports, and relevant literature to build foundational knowledge.
Gap Analysis: Identify gaps in existing knowledge or areas where further exploration is needed.
4. Select Research Methodology and Tools
Methodological Approach: Choose appropriate research methods such as surveys, interviews, focus groups, or data analytics.
Tools and Resources: Select tools like Google Forms for surveys, analytics platforms (e.g., SimilarWeb, Statista), and expert consultations.
5. Ethical Considerations and Compliance
Ethical Approval: Ensure compliance with ethical guidelines for research involving human subjects.
Data Privacy: Implement measures to protect participant confidentiality and adhere to data protection regulations (e.g., GDPR, HIPAA).
6. Budget and Resource Allocation
Resource Planning: Allocate resources including time, budget, and personnel required for each phase of the research.
Contingency Planning: Anticipate and plan for unforeseen challenges or adjustments to the research plan.
7. Develop Research Instruments
Survey Design: Create well-structured surveys using tools like Google Forms to gather quantitative data.
Interview and Focus Group Guides: Prepare detailed scripts and discussion points for qualitative data collection.
8. Sampling Strategy
Sampling Design: Define the sampling frame, size, and method (e.g., random sampling, stratified sampling) to ensure representation of target demographics.
Participant Recruitment: Plan recruitment strategies to reach and engage the intended participant groups effectively.
9. Data Collection and Analysis Plan
Data Collection: Implement methods for data gathering, ensuring consistency and validity.
Analysis Techniques: Decide on analytical approaches (e.g., statistical
Simple Steps to Make Her Choose You Every DayLucas Smith
Simple Steps to Make Her Choose You Every Day" and unlock the secrets to building a strong, lasting relationship. This comprehensive guide takes you on a journey to self-improvement, enhancing your communication and emotional skills, ensuring that your partner chooses you without hesitation. Forget about complications and start applying easy, straightforward steps that make her see you as the ideal person she can't live without. Gain the key to her heart and enjoy a relationship filled with love and mutual respect. This isn't just a book; it's an investment in your happiness and the happiness of your partner
Cyclothymia Test: Diagnosing, Symptoms, Treatment, and Impact | The Lifescien...The Lifesciences Magazine
The cyclothymia test is a pivotal tool in the diagnostic process. It helps clinicians assess the presence and severity of symptoms associated with cyclothymia.
Malayali Kerala Spa in Ajman, one among the top rated massage centre in ajman, welcomes you to experience high quality massage services from massage staffs from all ove rthe world! Being the best spa massage service providers, we take pride in offering traditional massage services of different countries, like
Indian Massage, Kerala Massage, Thai Massage, Pakistani Massage, Russian Massage etc
If you are seeking relaxation, pain relief, or wellness experience, our ajman spa is here for your unique needs and concerns. The services of our experienced therapists, and personalized attention will ensure that each visit will be memorable for you.
Book your appointment today and let us take you to a world of serenity and self-care. Because you deserves the best.
8. CONTRAINDICATIONS: MOVEMENT IN YOGA
8. Introduction to Contraindications
Students come to yoga classes with a variety of physical, mental, and emotional conditions that should be given special attention and support by teachers.
While making clear the distinction between yoga teacher and licensed medical or mental health professional, as teachers we are responsible for creating a safe and supportive environment for all students, including those with injuries, depression, age-related needs, and conditions such as pregnancy and menopause.
Here we will look at practical approaches to working with students whose bodies, hearts, and minds (which are not really separate) indicate the need for special accommodation in classes or in one-on-one sessions. Bringing a specifically yogic perspective to this aspect of teaching starts with looking at and appreciating every student as the whole person he or she is, offering tools and techniques for using various challenging conditions to heal, feel better, and move into a deeper quality of integration.
2024 Media Preferences of Older Adults: Consumer Survey and Marketing Implica...Media Logic
When it comes to creating marketing strategies that target older adults, it is crucial to have insight into their media habits and preferences. Understanding how older adults consume and use media is key to creating acquisition and retention strategies. We recently conducted our seventh annual survey to gain insight into the media preferences of older adults in 2024. Here are the survey responses and marketing implications that stood out to us.
At Malayali Kerala Spa Ajman we providing the top quality massage services for our customers.
Our massage center prioritizes efficiency to ensure a quality massage experience for our clients at Malayali Kerala Spa Ajman. We offer a convenient appointment system and precise massage services.
Reach us at Villa No 7, Near Ammar Bin Yasir Street Al Rashidiya 2 - Ajman - United Arab Emirates.
Phone : +971 529818279
Nursing management of the patient with Tonsillitis PPTblessyjannu21
Prepared by Prof. Blessy Thomas MSc Nursing, FNCON, SPN. The tonsils are two small glands that sit on either side of the throat.
In young children, they help to fight germs and act as a barrier against infection.
Tonsils act as filters, trapping germs that could otherwise enter the airways and cause infection.
They also make antibodies to fight infection.
But sometimes, they get overwhelmed by bacteria or viruses.
This can make them swollen and inflamed.
Tonsillitis is an infection of the tonsils, two masses of tissue at the back of the throat.
Tonsillitis is inflammation of the tonsils, two oval-shaped pads of tissue at the back of the throat — one tonsil on each side.
Tonsillitis is common, especially in children.
It can happen once in a while or come back again and again in a short period.Nursing management of Tonsillitis is important.
A comprehensive understanding of the operations for management of Tonsillitis and areas requiring special attention would be important.
Test bank clinical nursing skills a concept based approach 4e pearson educati...rightmanforbloodline
Test bank clinical nursing skills a concept based approach 4e pearson education
Test bank clinical nursing skills a concept based approach 4e pearson education
Test bank clinical nursing skills a concept based approach 4e pearson education
Test bank clinical nursing skills a concept based approach 4e pearson educati...
Volume status and fluid overload in peritoneal dialysis
1. Volume status and fluid
overload in peritoneal dialysis
Yousaf khan
Lecturer Renal dialysis
IPMS- KMU
2. Introduction
Fluid overload can manifest in obvious fashion as hypertension or
edema in PD patients.
Making it difficult to diagnose clinically chronic hypervolemia can
lead to LVH.
Major contributor to cardiovascular disease, in PD patient with
attendant morbidity and mortality.
Fluid overload with peritoneal membrane dysfunction is a common
cause for technique failure.
Assessment of fluid status
Mechanism of fluid overload
Diagnosis of ultrafiltration failure ( UFF)
3. 1: Assessment of fluid status:
Clinical examination
Laboratory investigation have so far not proven clinically useful
Target body weight for PD is that which gives a well tolerated
normotensive and edema free state
2: Mechanisms of fluid overload:
Fluid overload reflects a combination of inappropriate
prescription, noncompliance, loss of residual renal function,
mechanical problems and peritoneal membrane dysfunction.
3: Diagnosis of Ultra filtration failure (UFF):
High transporter with UFF (type I)
Low transporter with UFF (type II)
4. Diagnosis of Ultra filtration failure (UFF):
High transporter with UFF (type I)
In this situation the dialysate dextrose concentration falls rapidly
after infusion, resulting in loss of the concentration gradient that
drives fluid removal.
Most common cause and is often called type I UFF
Develops after 3 or more years on PD.
Its reflect an increase membrane vascularity that occurs with time
on PD, to a greater extent in some patients
Cause of increase effective surface area may include cumulative
exposure of the membrane to high glucose loads.
Low transporter with UFF (type II)
Group of patients has reduced small solute clearance.
A normal or reduce glucose absorption profile and reduce fluid
removal
Called type II UFF
Much less common
Its reflects decrease membrane surface and is most often due to
adhesions and scarring after a severe peritonitis or other intra
abdominal complication.
5. Causes of fluid overload in PD patients
Inappropriate bag selection
Inappropriate prescription for membrane transport status
long, dextrose – containing daytime or nocturnal dwells
Failure to optimize APD regimen for transport status
Failure to use icodextrin – containing solutions
Noncompliance with PD prescription
Noncompliance with salt and water restriction
Loss of residual renal function
Abdominal leak
Catheter malfunction
Poor blood glucose control
Peritoneal membrane dysfunction
6. Management of fluid overload
Sodium restriction
Patient education regarding when to select higher dextrose
solutions
Good blood glucose control
Preserve residual renal function
Abdominal leak
Catheter malfunction
Preservation of peritoneal membrane function
7. Hypertension and Hypotension in PD
Hypertension:
PD providing better blood pressure control than hemodialysis b/c
of its continuous nature.
More recently concern has been raised about blood pressure
control with CAPD
It has been demonstrate that antihypertensive medication
requirements with increase duration on CAPD, as compare
hemodialysis
Sodium sieving and removal
Management:
Initially volume control and antihypertensive should be introduce
only if his approach has been unsuccessful.
Preference should be given to agent that have a beneficial effect
on residual renal function, such as loop diuretics, ACE inhibitors
and ARB
8. Hypotension
Hypotension is not uncommon in PD population
Cause of hypotension is sometimes unclear but
approximately 20% of cases are secondary to heart failure.
40% may due to hypovolemia